These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

998 related articles for article (PubMed ID: 16648506)

  • 21. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
    Douillard JY; Hoff PM; Skillings JR; Eisenberg P; Davidson N; Harper P; Vincent MD; Lembersky BC; Thompson S; Maniero A; Benner SE
    J Clin Oncol; 2002 Sep; 20(17):3605-16. PubMed ID: 12202661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report].
    Tsuji Y; Yoshihito H; Nakamura T; Watanabe Y; Nakayama N; Ohi M; Kawanishi J; Handa H; Honjo K; Uehara S
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():439-46. PubMed ID: 8849290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
    Bhandari MS; Pienta KJ; Fardig J; Olson K; Smith DC
    Cancer; 2006 Apr; 106(8):1715-21. PubMed ID: 16534795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1).
    Baumgaertner I; Quinaux E; Khalil A; Louvet C; Buyse M; de Gramont A; André T;
    Clin Colorectal Cancer; 2010 Apr; 9(2):E5-10. PubMed ID: 20378497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer.
    Hsieh CH; Chen YJ; Chang KH; Hsu HH; Liu CK; Hung SK; Chen HW; Lai YL; Hsu TC
    Anticancer Res; 2006; 26(5B):3709-15. PubMed ID: 17094389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
    Mizushima T; Mizuno H; Ito T; Hoki M; Souma Y; Iwamoto T; Ozawa H; Kanou T; Nakamori Y; Iwase K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):941-4. PubMed ID: 16835484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
    Hochster HS; Luo W; Popa EC; Lyman BT; Mulcahy M; Beatty PA; Benson AB
    J Clin Oncol; 2007 Dec; 25(34):5397-402. PubMed ID: 18048821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
    Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
    Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-related quality of life in patients with colorectal cancer who receive oral uracil and tegafur plus leucovorin.
    Tsunoda A; Nakao K; Watanabe M; Matsui N; Tsunoda Y
    Jpn J Clin Oncol; 2010 May; 40(5):412-9. PubMed ID: 20085907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.
    Lin PC; Chen WS; Chao TC; Yang SH; Tiu CM; Liu JH
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):351-6. PubMed ID: 17111120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer.
    Hsiao SC; Lin JF; Chuang MT; Lee YA; Wu DL
    Int Surg; 2009; 94(4):298-303. PubMed ID: 20302025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UFT/leucovorin vs 5-FU/leucovorin in colon cancer.
    Smith RE; Lembersky BC; Wieand HS; Colangelo L; Mamounas EP
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):24-7. PubMed ID: 11098486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer.
    Kim DJ; Kim TI; Suh JH; Cho YS; Shin SK; Kang JK; Kim NK; Kim WH
    Yonsei Med J; 2003 Aug; 44(4):665-75. PubMed ID: 12950123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized crossover trial of intravenous 5-FU versus oral UFT both modulated by leucovorin: a one-centre experience.
    Lima AP; del Giglio A
    Eur J Cancer Care (Engl); 2005 May; 14(2):151-4. PubMed ID: 15842464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
    Hortobagyi GN; Young RR; Karwal M; Ibrahim NK; Hermann R; Murray JL; Watkins SP; Gore I
    Cancer; 2010 May; 116(10):2301-6. PubMed ID: 20225231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer.
    Byström P; Frödin JE; Berglund A; Wilking N; Glimelius B
    Radiother Oncol; 2004 Feb; 70(2):171-5. PubMed ID: 15028404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.